EU Health Regulator Clears Use of AI Tool in Fatty Liver Disease Trials
(Reuters) -A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool ...
The Financial Express5h
Can fatty liver lead to liver failure? Signs, risks, and when to worry
In the early stages, fatty liver may be asymptomatic, with most people unaware they have it. However, continued fat buildup ...
Khaleej Times2d
EU health regulator clears use of AI tool in fatty liver disease trials
tool called AIM-NASH in clinical trials to help identify the severity of a type of fatty liver disease. The condition, called metabolic dysfunction-associated steatohepatitis, or MASH, is a ...
Your blood pressure could be silently damaging your liver: Watch out for these warning signs
The doctor explained that beside alcohol consumption and hepatitis, hypertension can contribute significantly to liver fibrosis.
Frontiers3d
NAFLD treatment in diabetes: from current dietary interventions to novel treatment
Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disease worldwide affecting approximatively 20–30% ...
Nature5d
Non-alcoholic steatohepatitis articles from across Nature Portfolio
It is the progressive form of non-alcoholic fatty liver disease (NAFLD). NASH can lead to cirrhosis and liver cancer. Shumbayawonda et al. examine the impact of multi-parametric MRI in managing ...
Dr Boreham’s Crucible: This rare blood disease tackler aims to hit investors with its best shot
While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...
The Indian Express1d
EU health regulator clears use of AI tool in fatty liver disease trials
A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH in clinical trials to help identify the severity of a type of fatty liver ...